Groowe Groowe / Newsroom / ONCY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ONCY News

Oncolytics Biotech, Inc. Common Shares

The $71 Billion Cancer Shift: Why The FDA Is Speeding Up

globenewswire.com
PRLD MRNA IMNM AUTL ONCY

Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

prnewswire.com
AMGN ONCY CGON ISRL

Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

globenewswire.com
ONCY

$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium

prnewswire.com
ABBV ONCY GMAB GLSI ADCT

$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors

prnewswire.com
ONCY RNXT VSTM PFE CATX

Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment

prnewswire.com
ACRV BNTX IBRX ONCY MAIA

Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks

prnewswire.com
ONCY CHRS MRNA VIR MRK

THE RESILIENCE DOCTRINE: 5 Assets Securing the 2026 Sovereign Stack

globenewswire.com
ONCY

Oncolytic Virotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

globenewswire.com
TILT ONCY

Oncolytics Biotech® Announces Results of Special Meeting of Shareholders

globenewswire.com
ONCY